Company Analysis DENTSPLY SIRONA
1. Summary
Advantages
- Dividends (2.05%) are higher than the sector average (0.5496%).
- The stock's return over the last year (-18.15%) is higher than the sector average (-49.7%).
Disadvantages
- Price (23.36 $) is higher than fair price (5.99 $)
- Current debt level 29.5% has increased over 5 years from 19.1%.
- The company's current efficiency (ROE=-4.01%) is lower than the sector average (ROE=9.61%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| DENTSPLY SIRONA | Healthcare | Index | |
|---|---|---|---|
| 7 days | 23.7% | 2.5% | 1.3% |
| 90 days | -5.5% | -35.8% | 13% |
| 1 year | -18.1% | -49.7% | 37.1% |
XRAY vs Sector: DENTSPLY SIRONA has outperformed the "Healthcare" sector by 31.55% over the past year.
XRAY vs Market: DENTSPLY SIRONA has significantly underperformed the market by -55.26% over the past year.
Stable price: XRAY is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: XRAY with weekly volatility of -0.349% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (23.36 $) is higher than the fair price (5.99 $).
Price is higher than fair: The current price (23.36 $) is 74.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (126.19) is higher than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (126.19) is higher than that of the market as a whole (48.12).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.27) is lower than that of the sector as a whole (4.82).
P/BV vs Market: The company's P/BV (2.27) is lower than that of the market as a whole (3.1).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.88) is lower than that of the sector as a whole (33.76).
P/S vs Market: The company's P/S indicator (1.88) is lower than that of the market as a whole (10.15).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (14.78) is higher than that of the sector as a whole (-22.12).
EV/Ebitda vs Market: The company's EV/Ebitda (14.78) is lower than that of the market as a whole (18.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -30.04% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-30.04%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.16%).
5.4. ROE
ROE vs Sector: The company's ROE (-4.01%) is lower than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (-4.01%) is lower than that of the market as a whole (10.88%).
5.5. ROA
ROA vs Sector: The company's ROA (-1.79%) is lower than that of the sector as a whole (0.3359%).
ROA vs Market: The company's ROA (-1.79%) is lower than that of the market as a whole (6.5%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (6.27%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (6.27%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 2.05% is higher than the average for the sector '0.5496%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.05% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 2.05% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (99.07%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 08.08.2024 | LUCIER GREGORY T Director |
Purchase | 24.35 | 199 962 | 8 212 |
| 03.05.2022 | BRANDT ERIC Director |
Sale | 39.71 | 273 999 | 6 900 |
| 03.05.2022 | BRANDT ERIC Director |
Purchase | 38.02 | 262 338 | 6 900 |
| 04.03.2021 | ALFANO MICHAEL C Director |
Sale | 58.99 | 109 132 | 1 850 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
